In this sense, non-conventional biomarkers such as NGAL, MCP-1, KIM-1, and nephrin are described in recent studies as promising for the early assessment of AKI due to their high sensitivity, showing a significant increase in several clinical contexts even before the manifestation of classic signs and symptoms of AKI34. Here, CCL2 is linked to acute kidney injury.